Consulting Pharma Pharma reps 
Pharma Marketing Network
MARCH 19, 2025
But how can pharma brands create meaningful connections in a digital landscape crowded with content? Unlike traditional consumer marketing, pharma marketing requires a strategic approach that balances compliance, education, and innovation. Pharma marketers must strike a balance between compliance and engagement.
Pharma Marketing Network
APRIL 9, 2025
In a world dominated by digital conversations, failing to master pharma digital marketing is no longer an optionits a risk to market performance. Pharma marketers today must navigate not only consumer expectations but also a tightly regulated environment. Pharma brands were forced to adapt rapidly.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
OCTOBER 13, 2020
Below is a Q&A with Mark Bard, Co-Founder of The DHC Group, who offers his insights on the challenges COVID-19 has brought to pharma, as well as what innovation is taking place due to this full shift to digital and what lies ahead in the future. How does the situation impact pharma? Does that mean they have no access?
Veeva
AUGUST 22, 2021
The findings presented here are based on pharma sales rep activities that were captured in Veeva CRM between 1 January 2020 and 5 April 2021. Before COVID-19, pharmaceutical sales reps had been accustomed to meeting HCPs in person. Digital channels are here to stay and to help pharma companies succeed. About Veeva.
Veeva
APRIL 7, 2022
The most impactful way for pharmas to plan their engagement strategies is using the omnichannel approach. True omnichannel planning means executing on all channels available to the reps, using a multi-faceted approach to maximise results. In Q4 2021 when some face-to-face interactions returned, the number reduced only to 289,511.
PM360
DECEMBER 20, 2023
From direct peer consultation to private groups, to journal clubs, to following Digital Opinion Leaders (DOLs) social media has become part of an HCP’s clinical toolkit. HCPs are pressed for time, eager to keep up with scientific and clinical developments, skeptical about big pharma, and increasingly focused on outcomes and metrics.
Veeva
FEBRUARY 6, 2022
According to Veeva Pulse data , COVID-19 has accelerated the shift to digital for life sciences, with significant growth in remote and digital engagement since early 2020, and a 10X increase of HCPs using three or more channels in their engagement with pharma 1. Get stakeholder buy in on the “why”. About Veeva.
Expert insights. Personalized for you.
52 
Let's personalize your content